A gold-catalyzed 1,2-oxyalkynylation of N-allenamides with ethylnylbenziodoxolones (EBXs) has been achieved for the first time. The reaction, which follows a redox-neutral Au(I)/Au(III) catalytic pathway, was enabled in an attempt to exhaust the EBX reagents atom-economically by putting the nucleophilic carboxylate part of EBXs to appropriate use. This constitutes the first example for gold-catalyzed β-alkynylation of N-allenamides to construct highly valuable 1,3-enynes. The potential of the sequence is further documented by some follow-up transformations.
By applying the “interplay”
mode, which consolidates
two key reactivity modes of gold catalysis, namely π-activation
mode and cross-coupling mode, the first alkynylative Meyer–Schuster
rearrangement is designed and successfully implemented. The current
protocol gives straightforward access to enynones, a highly valuable
building block, from easily available propargyl alcohol feedstocks.
Control experiments suggest an Au(III) catalyst triggers the Meyer–Schuster
rearrangement, whereas monitoring the reaction with ESI-HRMS provided
strong evidence in favor of a key alkynylgold(III) intermediate which
supports the proposed “interplay” scenario.
Immunogenic Cell Death (ICD) is a unique cell death mechanism that kills cancer cells while rejuvenating the anticancer immunosurveillance, thereby benefiting the clinical outcomes of various immuno-chemotherapeutic regimens. Herein, we...
It takes two to tango: an experimental and computational study of ionic liquid crystals reveals the subtle balance between the energetic interactions in the hydrophobic and ionic layers that contribute to the stabilization of the ionic smectic phase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.